期刊: BLADDER CANCER, 2021; 7 (2)
BACKGROUND: Bladder cancer is still a disease of significant morbidity and mortality. In bladder cancer, RB1 is one of the most common mutant genes. M......
期刊: BLADDER CANCER, 2022; 8 (1)
BACKGROUND: Bladder urothelial carcinoma is the most prevalent type of bladder cancer, characterized by drug resistance, high recurrence rate, and unf......
期刊: BLADDER CANCER, 2022; 8 (3)
BACKGROUND: Bladder cancer (BCa) is one of the most prevalent malignancies and more common in men. An aberrantly expressed long noncodingRNA(lncRNA) h......
期刊: BLADDER CANCER, 2022; 8 (4)
BACKGROUND: T1 substaging is a predictive factor for non-muscle-invasive bladder cancer, and two types of T1 substaging systems (T1a/b/c and T1m/e) ar......
期刊: BLADDER CANCER, 2022; 8 (2)
BACKGROUND: Bladder cancer is the second most common urological cancer worldwide, with low early diagnosis and high mortality. The limited progress in......